Related Experiment Video
Updated: Jun 30, 2026

Disposable Dosators Intended for Dry Powder Delivery to Mice
Published on: August 18, 2023
Selecting the Optimal Inhaler in Asthma: Respiratory and Peripheral Muscle Strength as Predictors of DPI and MDI
Buğra Kerget1,2, Alperen Aksakal1, Sırma Merve Çetin2
1Department of Pulmonary Diseases, Ataturk University School of Medicine, Erzurum, Turkey.
Background:
Asthma is characterized by variable airway obstruction, and proper inhaler choice and use are critical for effective treatment. This study aimed to identify factors influencing treatment response in newly diagnosed patients started on dry powder inhalers (DPIs) or metered-dose inhalers (MDIs).
Methods:
Between March and September 2025, 177 newly diagnosed asthma patients were screened. Eighty patients with at least high-school education, correct inhaler use, and good adherence were included (40 DPI, 40 MDI). Pulmonary function, respiratory muscle strength, Asthma Control Test (ACT), and handgrip strength (HGS) were assessed at baseline and after one month.
Results:
After one month, improvements in forced expiratory volume in 1 second (FEV1) (% predicted), maximum inspiratory pressure (MIP) and MIP (%), and maximum expiratory pressure (MEP) (%) were significantly greater in the DPI group compared with the MDI group (p = 0.03, 0.04, 0.02 respectively). In multivariate regression, among MDI users, MIP (kPa) (B = -11.305, p = 0.001), MIP (%) (B = -0.902, p = 0.003), ACT (B = 1.277, p = 0.014), and HGS (B = 0.103, p = 0.039) were independent predictors of ΔFEV1 (%). Among DPI users, MIP (kPa) (B = 11.987, p = 0.015), MIP (%) (B = 1.041, p = 0.009), MEP (kPa) (B = -6.554, p = 0.014), MEP (%) (B = -0.816, p < 0.001), and HGS (B = 0.201, p = 0.005) were significant determinants of ΔFEV1.
Conclusion:
DPIs may be preferable for patients with higher inspiratory muscle strength, whereas MDIs may be better for those with lower MIP. HGS appears to be an important factor for both inhaler control and treatment efficacy.
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

